US HB7528 | 2025-2026 | 119th Congress
Status
Sponsorship: Partisan Bill (Republican 1)
Status: Introduced on February 12 2026 - 25% progression
Action: 2026-02-12 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 12 2026 - 25% progression
Action: 2026-02-12 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage.
Title
GAP Supply Act Growing America’s Pharmaceutical Supply Act
Sponsors
| Rep. Earl Carter [R-GA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2026-02-12 | House | Referred to the House Committee on Energy and Commerce. |
| 2026-02-12 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/house-bill/7528/all-info |
| Text | https://www.congress.gov/119/bills/hr7528/BILLS-119hr7528ih.pdf |
